The influence of oral combined oral contraceptive with estradiol valerate and dienogest  on hemostatic system (a review)

O. R. Grigoryan; Е. Н. Андреева

doi:10.17116/repro201521214-17

The influence of oral combined oral contraceptive with estradiol valerate and dienogest on hemostatic system (a review)

O. R. Grigoryan, Е. Н. Андреева

In: Problemy reproduktsii · 2015 · vol. 21(2) , pp. 14 · doi:10.17116/repro201521214-17 · W2318593681

article OA: bronze CC0

🔓 Open OA copy View on OpenAlex View at publisher

⚙ AI-generated summary by claude@2026-06, 2026-06-08 ⓘ

This review examines the influence of oral combined oral contraceptives containing estradiol valerate and dienogest on the hemostatic system.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (18)

Bleeding pattern and cycle control with an estradiol-based oral contraceptive: a seven-cycle, randomized comparative trial of estradiol valerate/dienogest and ethinyl estradiol/levonorgestrel via openalex
Effect of four oral contraceptives on hemostatic parameters via openalex
Effects of a combined oral contraceptive containing oestradiol valerate/dienogest on hormone withdrawal-associated symptoms: Results from the multicentre, randomised, double-blind, active-controlled HARMONY II study via openalex
Efficacy and bleeding profile of a combined oral contraceptive containing oestradiol valerate/dienogest: A pooled analysis of three studies conducted in North America and Europe via openalex
Hemostatic Effects of a Novel Estradiol-Based Oral Contraceptive via openalex
Noncontraceptive benefits of the estradiol valerate/dienogest combined oral contraceptive: a review of the literature via openalex
Ovulation inhibition with four variations of a four-phasic estradiol valerate/dienogest combined oral contraceptive: results of two prospective, randomized, open-label studies via openalex
Resistance to APC and SHBG levels during use of a four-phasic oral contraceptive containing dienogest and estradiol valerate: a randomized controlled trial via openalex
doi:10.1046/j.1365-2141.1997.192707.x via openalex
doi:10.1542/peds.2010-2221 via openalex
doi:10.3109/00016348209155333 via openalex
doi:10.1016/j.ogc.2006.05.003 via openalex
doi:10.1111/j.1365-2141.2007.06973.x via openalex
doi:10.1016/0002-9378(82)90218-6 via openalex
W2616068419 via openalex
doi:10.1016/0378-5122(89)90251-x via openalex
doi:10.1055/s-0038-1646528 via openalex
doi:10.1016/j.contraception.2005.09.015 via openalex

Source provenance

openalex: last seen: 2026-05-10T11:08:07.918008+00:00

License: CC0 · commercial use OK

[1] Bleeding pattern and cycle control with an estradiol-based oral contraceptive: a seven-cycle, randomized comparative trial of estradiol valerate/dienogest and ethinyl estradiol/levonorgestrel via openalex

[2] Effect of four oral contraceptives on hemostatic parameters via openalex

[3] Effects of a combined oral contraceptive containing oestradiol valerate/dienogest on hormone withdrawal-associated symptoms: Results from the multicentre, randomised, double-blind, active-controlled HARMONY II study via openalex

[4] Efficacy and bleeding profile of a combined oral contraceptive containing oestradiol valerate/dienogest: A pooled analysis of three studies conducted in North America and Europe via openalex

[5] Hemostatic Effects of a Novel Estradiol-Based Oral Contraceptive via openalex

[6] Noncontraceptive benefits of the estradiol valerate/dienogest combined oral contraceptive: a review of the literature via openalex

[7] Ovulation inhibition with four variations of a four-phasic estradiol valerate/dienogest combined oral contraceptive: results of two prospective, randomized, open-label studies via openalex

[8] Resistance to APC and SHBG levels during use of a four-phasic oral contraceptive containing dienogest and estradiol valerate: a randomized controlled trial via openalex

[9] doi:10.1046/j.1365-2141.1997.192707.x via openalex

[10] doi:10.1542/peds.2010-2221 via openalex

[11] doi:10.3109/00016348209155333 via openalex

[12] doi:10.1016/j.ogc.2006.05.003 via openalex

[13] doi:10.1111/j.1365-2141.2007.06973.x via openalex

[14] doi:10.1016/0002-9378(82)90218-6 via openalex

[15] W2616068419 via openalex

[16] doi:10.1016/0378-5122(89)90251-x via openalex

[17] doi:10.1055/s-0038-1646528 via openalex

[18] doi:10.1016/j.contraception.2005.09.015 via openalex